Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development

Go back to Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
(NASDAQ: NKTX) Delayed: 2.30 -0.11 (4.56%)
Previous Close $2.41    52 Week High
Open $2.39    52 Week Low
Day High $2.40    P/E N/A 
Day Low $2.27    EPS
Volume 944,986